1.
Frisch A, Krayem B, Zuckerman T, Henig I, Yehudai-Ofir D, Glaubach N. Intensive induction therapy with FLAG-idarubicinvenetoclax for fit older high-risk patients with acute myeloid leukemia. Haematologica 2026; 111(8):2848-2851; https://doi.org/10.3324/haematol.2025.300442.